Mohammad W. Aref

409 total citations
20 papers, 313 citations indexed

About

Mohammad W. Aref is a scholar working on Orthopedics and Sports Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Mohammad W. Aref has authored 20 papers receiving a total of 313 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Orthopedics and Sports Medicine, 8 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in Mohammad W. Aref's work include Bone health and osteoporosis research (12 papers), Bone health and treatments (8 papers) and Parathyroid Disorders and Treatments (6 papers). Mohammad W. Aref is often cited by papers focused on Bone health and osteoporosis research (12 papers), Bone health and treatments (8 papers) and Parathyroid Disorders and Treatments (6 papers). Mohammad W. Aref collaborates with scholars based in United States, Italy and Poland. Mohammad W. Aref's co-authors include Matthew R. Allen, Erin McNerny, Sharon M. Moe, Drew M. Brown, Joseph M. Wallace, Lilian I. Plotkin, Hannah M. Davis, Jason M. Organ, Elizabeth A. Swallow and Kenneth E. White and has published in prestigious journals such as PLoS ONE, The FASEB Journal and Bone.

In The Last Decade

Mohammad W. Aref

20 papers receiving 313 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mohammad W. Aref United States 11 136 115 90 80 44 20 313
Heather B. Hunt United States 8 220 1.6× 112 1.0× 34 0.4× 81 1.0× 59 1.3× 12 360
Shi Shou Lu United States 9 198 1.5× 254 2.2× 61 0.7× 252 3.1× 40 0.9× 13 429
Clifford J. Rosen United States 8 180 1.3× 176 1.5× 23 0.3× 153 1.9× 34 0.8× 9 382
C. Bertholon France 9 172 1.3× 147 1.3× 18 0.2× 118 1.5× 52 1.2× 12 367
Panagiota Andreopoulou United States 7 121 0.9× 98 0.9× 280 3.1× 225 2.8× 103 2.3× 11 476
R. Zoehrer Austria 9 336 2.5× 218 1.9× 32 0.4× 187 2.3× 77 1.8× 12 524
Carol L. Paddock United States 8 308 2.3× 204 1.8× 32 0.4× 208 2.6× 45 1.0× 8 434
Masae Goseki Japan 11 73 0.5× 113 1.0× 33 0.4× 22 0.3× 30 0.7× 17 342
Aurore Varela United States 12 358 2.6× 286 2.5× 62 0.7× 295 3.7× 85 1.9× 18 503
Jan Mettelsiefen Germany 5 136 1.0× 124 1.1× 11 0.1× 78 1.0× 89 2.0× 6 340

Countries citing papers authored by Mohammad W. Aref

Since Specialization
Citations

This map shows the geographic impact of Mohammad W. Aref's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammad W. Aref with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammad W. Aref more than expected).

Fields of papers citing papers by Mohammad W. Aref

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohammad W. Aref. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammad W. Aref. The network helps show where Mohammad W. Aref may publish in the future.

Co-authorship network of co-authors of Mohammad W. Aref

This figure shows the co-authorship network connecting the top 25 collaborators of Mohammad W. Aref. A scholar is included among the top collaborators of Mohammad W. Aref based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohammad W. Aref. Mohammad W. Aref is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Swallow, Elizabeth A., Mohammad W. Aref, Corinne E. Metzger, et al.. (2019). Skeletal levels of bisphosphonate in the setting of chronic kidney disease are independent of remodeling rate and lower with fractionated dosing. Bone. 127. 419–426. 8 indexed citations
2.
Davis, Hannah M., et al.. (2019). Short-term pharmacologic RAGE inhibition differentially affects bone and skeletal muscle in middle-aged mice. Bone. 124. 89–102. 31 indexed citations
3.
4.
Clinkenbeard, Erica L., Megan L. Noonan, Joseph C. Thomas, et al.. (2019). Increased FGF23 protects against detrimental cardio-renal consequences during elevated blood phosphate in CKD. JCI Insight. 4(4). 45 indexed citations
5.
Aref, Mohammad W., Elizabeth A. Swallow, Corinne E. Metzger, et al.. (2019). Parathyroid suppression therapy normalizes chronic kidney disease-induced elevations in cortical bone vascular perfusion: a pilot study. Osteoporosis International. 30(8). 1693–1698. 4 indexed citations
6.
Davis, Hannah M., Rafael Pacheco‐Costa, Emily G. Atkinson, et al.. (2019). Osteocytic miR21 deficiency improves bone strength independent of sex despite having sex divergent effects on osteocyte viability and bone turnover. FEBS Journal. 287(5). 941–963. 13 indexed citations
7.
Pacheco‐Costa, Rafael, Hannah M. Davis, Emily G. Atkinson, et al.. (2018). Reversal of loss of bone mass in old mice treated with mefloquine. Bone. 114. 22–31. 9 indexed citations
8.
Davis, Hannah M., Mohammad W. Aref, Alexandra Aguilar‐Perez, et al.. (2018). Cx43 Overexpression in Osteocytes Prevents Osteocyte Apoptosis and Preserves Cortical Bone Quality in Aging Mice. JBMR Plus. 2(4). 206–216. 45 indexed citations
9.
Aref, Mohammad W., Elizabeth A. Swallow, Neal X. Chen, Sharon M. Moe, & Matthew R. Allen. (2018). Skeletal vascular perfusion is altered in chronic kidney disease. Bone Reports. 8. 215–220. 3 indexed citations
10.
Swallow, Elizabeth A., Mohammad W. Aref, Max A. Hammond, et al.. (2018). Skeletal accumulation of fluorescently tagged zoledronate is higher in animals with early stage chronic kidney disease. Osteoporosis International. 29(9). 2139–2146. 5 indexed citations
11.
Allen, Matthew R., Erin McNerny, Mohammad W. Aref, et al.. (2017). Effects of combination treatment with alendronate and raloxifene on skeletal properties in a beagle dog model. PLoS ONE. 12(8). e0181750–e0181750. 5 indexed citations
12.
Aref, Mohammad W., et al.. (2017). Raloxifene Improves Bone Mechanical Properties in Mice Previously Treated with Zoledronate. Calcified Tissue International. 101(1). 75–81. 10 indexed citations
13.
Allen, Matthew R. & Mohammad W. Aref. (2017). What Animal Models Have Taught Us About the Safety and Efficacy of Bisphosphonates in Chronic Kidney Disease. Current Osteoporosis Reports. 15(3). 171–177. 10 indexed citations
14.
Aref, Mohammad W., et al.. (2017). Assessment of regional bone tissue perfusion in rats using fluorescent microspheres. Bone Reports. 6. 140–144. 8 indexed citations
15.
Larsen, Rachel A., Debra L. Hickman, Mohammad W. Aref, et al.. (2017). Effects of daily restraint with and without injections on skeletal properties in C57BL/6NHsd mice. Lab Animal. 46(7). 299–301. 2 indexed citations
16.
17.
Aref, Mohammad W., Erin McNerny, Drew M. Brown, Karl J. Jepsen, & Matthew R. Allen. (2016). Zoledronate treatment has different effects in mouse strains with contrasting baseline bone mechanical phenotypes. Osteoporosis International. 27(12). 3637–3643. 11 indexed citations
18.
Aref, Mohammad W., Travis Lee Turnbull, Alex G. Robling, et al.. (2015). Development of an in vivo rabbit ulnar loading model. Bone. 75. 55–61. 23 indexed citations
19.
Aref, Mohammad W., Maxime A. Gallant, Jason M. Organ, et al.. (2013). In vivo reference point indentation reveals positive effects of raloxifene on mechanical properties following 6months of treatment in skeletally mature beagle dogs. Bone. 56(2). 449–453. 38 indexed citations
20.
Organ, Jason M., Maxime A. Gallant, Mohammad W. Aref, et al.. (2013). In vivo assessment of skeletal biomechanical properties reveals beneficial effects of combination anti‐remodeling drug treatment. The FASEB Journal. 27(S1). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Heather B. Hunt Breakdown of academic impact, for papers by Shi Shou Lu Breakdown of academic impact, for papers by Clifford J. Rosen Breakdown of academic impact, for papers by C. Bertholon Breakdown of academic impact, for papers by Panagiota Andreopoulou Breakdown of academic impact, for papers by R. Zoehrer Breakdown of academic impact, for papers by Carol L. Paddock Breakdown of academic impact, for papers by Masae Goseki Breakdown of academic impact, for papers by Aurore Varela Breakdown of academic impact, for papers by Jan Mettelsiefen
Rankless by CCL
2026